Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Anticoagulation Targets in ECLS
NCT04536272Phase 3Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2020
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin, low molecular weight heparin calcium in thrombosis, sponsored by University Medical Center Groningen. Started Oct 2020; status: completed.
02
Drugs
heparinlow molecular weight heparin calcium
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT04536272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536272.